All News about Biotricity IncVia ACCESSWIRE
Via Benzinga
Via Benzinga
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022
March 22, 2022
From Biotricity, Inc.
Via AccessWire
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|